⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL868180 | 1.00 | — | — | |
| SCHEMBL477907 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL19925326 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL19925325 | 0.95 | — | — | |
| SCHEMBL8671265 | 0.82 | ALDH1A1 (0.31) | — | |
| SCHEMBL1057489 | 0.80 | — | — | |
| SCHEMBL6382645 | 0.80 | — | — | |
| SCHEMBL27484672 | 0.79 | — | — | |
| SCHEMBL5200469 | 0.79 | — | — | |
| SCHEMBL868391 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 328 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4103559-B1 | HETEROCYCLIC PAD4 INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2026-03-04 | — | — | EP | claimed |
| EP-4322962-A1 | PHOSPHORUS DERIVATIVES AS NOVEL SOS1 INHIBITORS | Bayer Aktiengesellschaft (DE) | 2024-02-21 | — | — | EP | claimed |
| CN-117500507-A | Phosphorus derivatives as novel SOS1 inhibitors | 拜耳公司 | 2024-02-02 | — | — | CN | claimed |
| CN-111542526-B | Condensed imidazole derivatives substituted with tertiary hydroxyl groups as PI 3K-gamma inhibitors | 因赛特公司 | 2024-01-09 | — | — | CN | claimed |
| WO-2022219035-A1 | PHOSPHORUS DERIVATIVES AS NOVEL SOS1 INHIBITORS | BAYER AKTIENGESELLSCHAFT (DE) | 2022-10-20 | — | — | WO | claimed |
| CN-107406861-B | Industrial production method for chiral-1, 1-difluoro-2-propanol | 公立大学法人富山县立大学 | 2021-04-02 | — | — | CN | claimed |
| EP-3697789-A1 | CONDENSED IMIDAZOLE DERIVATIVES SUBSTITUTED BY TERTIARY HYDROXY GROUPS AS PI3K-GAMMA INHIBITORS | Incyte Corporation (US) | 2020-08-26 | — | — | EP | claimed |
| WO-2020004521-A1 | THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES, FIBROTIC DISEASES, AND CANCER DISEASES | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 2020-01-02 | — | — | WO | claimed |
| WO-2019079469-A1 | CONDENSED IMIDAZOLE DERIVATIVES SUBSTITUTED BY TERTIARY HYDROXY GROUPS AS PI3K-GAMMA INHIBITORS | INCYTE CORPORATION (US) | 2019-04-25 | — | — | WO | claimed |
| US-20180105840-A1 | PROCESS FOR INDUSTRIAL PRODUCTION OF CHIRAL-1,1-DIFLUORO-2-PROPANOL | PUBLIC UNIVERSITY CORPORATION TOYAMA PREFECTURAL UNIVERSITY (JP) | 2018-04-19 | — | — | US | claimed |
| EP-2492266-A1 | 5-HYDROXYPYRIMIDINE-4-CARBOXAMIDE DERIVATIVE | Daiichi Sankyo Company, Limited (JP) | 2012-08-29 | — | — | EP | claimed |
| WO-2010106352-A2 | VERTEBRATE TRAP | BIOTRONICS LIMITED (GB) | 2010-09-23 | — | — | WO | claimed |
| JP-2010529216-A | — | — | 2010-08-26 | — | — | JP | claimed |
| EP-2150573-A2 | CELLULOSE ESTERS WITH A HIGH HYDROXYL CONTENT AND THEIR USE IN LIQUID CRYSTAL DISPLAYS | Eastman Chemical Company (US) | 2010-02-10 | — | — | EP | claimed |
| EP-2057109-A2 | ADDITION REACTIONS USING TRANSITION METAL CATALYSTS IN HALOGENATED SOLVENTS | BASF SE (DE) | 2009-05-13 | — | — | EP | claimed |
| WO-2008143765-A2 | CELLULOSE ESTERS WITH A HIGH HYDROXYL CONTENT AND THEIR USE IN LIQUID CRYSTAL DISPLAYS | EASTMAN CHEMICAL COMPANY (US) | 2008-11-27 | — | — | WO | claimed |
| WO-2008046918-A2 | ADDITION REACTIONS USING TRANSITION METAL CATALYSTS IN HALOGENATED SOLVENTS | BASF SE (DE) | 2008-04-24 | — | — | WO | claimed |
| EP-1893562-A1 | REVERSIBLE INHIBITORS OF MONOAMINE OXIDASE A AND B | Merck Frosst Canada Ltd. (CA) | 2008-03-05 | — | — | EP | claimed |
| WO-2006133559-A1 | REVERSIBLE INHIBITORS OF MONOAMINE OXIDASE A AND B | MERCK FROSST CANADA LTD. (CA) | 2006-12-21 | — | — | WO | claimed |
| US-6022722-A | REGENERATION OF DENATURED POLYPEPTIDE; CONTACTING A DENATURED POLYPEPTIDE ADSORBED TO SOLID SUPPORT WITH TRIFLUOROETHANOL | HUELS AKTIENGESELLSCHAFT (DE) | 2000-02-08 | — | — | US | claimed |